Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Colorcon
AstraZeneca
Boehringer Ingelheim
Merck

Last Updated: March 22, 2023

Methylene blue - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


What are the generic drug sources for methylene blue and what is the scope of patent protection?

Methylene blue is the generic ingredient in one branded drug marketed by Provepharm Sas and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for methylene blue. One supplier is listed for this compound.

Summary for methylene blue
Recent Clinical Trials for methylene blue

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nanjing First Hospital, Nanjing Medical UniversityPhase 3
Hugh TaylorEarly Phase 1
Multidisciplinary Association for Psychedelic StudiesPhase 1

See all methylene blue clinical trials

Pharmacology for methylene blue
Medical Subject Heading (MeSH) Categories for methylene blue

US Patents and Regulatory Information for methylene blue

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Provepharm Sas PROVAYBLUE methylene blue SOLUTION;INTRAVENOUS 204630-002 Jul 18, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
Provepharm Sas PROVAYBLUE methylene blue SOLUTION;INTRAVENOUS 204630-001 Apr 8, 2016 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Express Scripts
Medtronic
Mallinckrodt
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.